500087 announcements Cipla Ltd. announcements and dividends declared BSE
Cipla Ltd. Complete list of announcements declared & dividend announcements by Cipla Ltd. 500087
Cipla Ltd. 500087 listed on BSE and deals inAnnouncements and dividends declared by Cipla Ltd. 500087
Cipla partners with Qilu to license, supply Keytruda biosimilar in US
Drug major Cipla Ltd on Thursday said its wholly owned subsidiary, Invagen Pharmaceuticals Inc, has entered into a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to the cancer drug Keytruda in the United States.
Announcement as on 04 September 2026
Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Cipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s cancer drug Keytruda. Qilu will handle development, approvals, manufacturing and supply, while Cipla USA will commercial
Announcement as on 04 September 2026
Cipla and SBP Group sign exclusive license agreement for Rolditamig Deuderuxtecan
Used in treatment of HER2-low advanced breast cancer
Announcement as on 31 August 2026
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations
Maharashtra FDA cancelled Cipla's Pune unit drug sale licences. Serious irregularities in storage and recall procedures were cited by the regulator. The company failed to fully comply with market recall directions for Reactin Plus Tablets. Further non-c
Announcement as on 28 August 2026
Pharma giant Cipla completes merger with wholly-owned subsidiary Inzpera Health Sciences
Pharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficient resource utilisation and greater economies of scale. The merger will improve operating parameters and maximise sha
Announcement as on 19 August 2026
Announcements by Cipla Ltd. first page | Next page |
500087 Cipla Ltd. current price & indicator signals
Recent prices of 500087 Cipla Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 04 Fri Sep 2026 | 1385.00 | 1375.85 to 1398.00 | -0.29% | 1.17 times |
| 03 Thu Sep 2026 | 1389.00 | 1388.50 to 1415.00 | -1.71% | 1 times |
| 02 Wed Sep 2026 | 1413.15 | 1402.00 to 1418.00 | -0.34% | 0.15 times |
| 01 Tue Sep 2026 | 1418.00 | 1407.00 to 1425.00 | 0.14% | 0.58 times |
| 31 Mon Aug 2026 | 1416.00 | 1410.45 to 1426.20 | -0.14% | 4.41 times |
| 28 Fri Aug 2026 | 1418.00 | 1409.70 to 1423.95 | -0.13% | 0.13 times |
| 27 Thu Aug 2026 | 1419.90 | 1401.85 to 1420.00 | 0.82% | 0.54 times |
| 26 Wed Aug 2026 | 1408.40 | 1400.40 to 1419.05 | -0.82% | 1.81 times |
| 25 Tue Aug 2026 | 1420.00 | 1412.20 to 1430.25 | -1.05% | 0.48 times |
| 24 Mon Aug 2026 | 1435.00 | 1411.00 to 1440.40 | 0.62% | 0.54 times |
| 21 Fri Aug 2026 | 1426.20 | 1408.70 to 1443.15 | -0.8% | 0.37 times |
| 20 Thu Aug 2026 | 1437.65 | 1426.85 to 1443.60 | 1.53% | 0.16 times |
Videos related to: 500087 announcements Cipla Ltd. announcements and dividends declared BSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


